As of 2026-06-14, the EV/EBITDA ratio of Acacia Pharma Group PLC (ACPH.BR) is -0.92. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ACPH.BR's latest enterprise value is 94.27 mil EUR. ACPH.BR's TTM EBITDA according to its financial statements is -102.90 mil EUR. Dividing these 2 quantities gives us the above ACPH.BR EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 3.5x - 6.0x | 4.4x |
| Forward P/E multiples | 5.2x - 6.1x | 5.4x |
| Fair Price | (4.70) - (5.40) | (4.42) |
| Upside | -629.6% - -707.8% | -597.5% |
| Date | EV/EBITDA |